Lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma; reciprocal stabilization of coagulation factor XIII-A and -B subunits; inotuzumab ozogamicin for MRD in ALL
This Blood Podcast episode covers lisocabtagene maraleucel for relapsed large B-cell lymphoma, reciprocal stabilization of coagulation factor XIII subunits, and inotuzumab ozogamicin for measurable residual disease in acute lymphoblastic leukemia.